The pathophysiology of chronic cardiorenal disease based on central hemodynamics
Journal Title: Journal of Cardiovascular Medicine and Cardiology - Year 2018, Vol 5, Issue 3
Abstract
As patients with chronic kidney disease (CKD) and chronic heart failure (CHF) increase, there is concern about a future heart failure pandemic. Deterioration of renal function is an independent prognostic factor for CHF after decongestion. Interactions between renal disease and cardiac disease are increasing, including nephrosclerosis and heart failure with preserved ejection fraction (HFpEF), which are both derived from augmentation of central pulse pressure by age-related arterial stiffening. Thus, it is necessary to treat multiple underlying diseases of cardiorenal syndrome simultaneously. However, an effective therapeutic strategy for HFpEF has not been established. This review reconsiders the pathophysiology of chronic cardiorenal disease related to arterial stiffening from the viewpoint of central hemodynamics and explores treatment options.
Authors and Affiliations
Ohno Michiya
Keywords
Related Articles
- EP ID EP523817
- DOI 10.17352/2455-2976.000067
- Views 80
- Downloads 0
Can Irisin be a New Agent Responsible for the Development of Heart Attack and Cardiac Cachexia?
Cardiac cachexia, a syndrome characterized by systemic destruction, nutritional impairment and weight loss [1], has a prevalence ranging between 8 and 42% around the world [2]. The syndrome was first described by the fat...
Can Strict Control of Renalase Present a New Treatment Alternative in Regulating Blood Pressure?
Blood pressure is the pressure the blood in arteries applies on vessels. Abnormal blood pressure is a major public health problem commonly encountered in the population with normal blood pressure and intensive care patie...
Bleeding Risk under Oral Factor Xa Inhibitors: Meta-analysis of the randomized comparison with Vitamin K Antagonists and Meta-Regression analysis
Background: Randomized trials have shown that oral direct factor Xa inhibitors (ODIXa) offer potential advantages over vitamin K antagonists (VKAs). It is however unclear whether the magnitude of their benefit is similar...
Cardiac Resynchronization Therapy in Heart Failure: Rationale, Results, Indications, Limits and Perspectives
Heart Failure is the result of heterogeneous structural heart diseases, especially ischemic disease, and is becoming increasingly common in all Western countries. Many patients continue to be symptomatic in spite of prog...
Oxidative Stress as “Mother” of Many Human Diseases at Strong Clinical Impact
Oxidative stress, characterized by the production in excess of free radicals, is the main aspect of all living systems which use oxygen to convert biochemical energy coming from nutrients into adenosine triphosphate. In...